Development of a RVFV ELISA that can distinguish infected from vaccinated animals
Open Access
- 13 August 2009
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 6 (1) , 125
Abstract
Background: Rift Valley Fever Virus is a pathogen of humans and livestock that causes significant morbidity and mortality throughout Africa and the Middle East. A vaccine that would protect animals from disease would be very beneficial to the human population because prevention of the amplification cycle in livestock would greatly reduce the risk of human infection by preventing livestock epizootics. A mutant virus, constructed through the use of reverse genetics, is protective in laboratory animal models and thus shows promise as a potential vaccine. However, the ability to distinguish infected from vaccinated animals is important for vaccine acceptance by national and international authorities, given regulations restricting movement and export of infected animals.Results: In this study, we describe the development of a simple assay that can be used to distinguish naturally infected animals from ones that have been vaccinated with a mutant virus. We describe the cloning, expression and purification of two viral proteins, and the development of side by side ELISAs using the two viral proteins.Conclusion: A side by side ELISA can be used to differentiate infected from vaccinated animals. This assay can be done without the use of biocontainment facilities and has potential for use in both human and animal populations.Keywords
This publication has 32 references indexed in Scilit:
- Prediction of a Rift Valley fever outbreakProceedings of the National Academy of Sciences, 2009
- Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated AnimalsJournal of Virology, 2008
- The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infectionVirology, 2007
- Adverse response of non‐indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccineJournal of Medical Virology, 2006
- Rescue of Infectious Rift Valley Fever Virus Entirely from cDNA, Analysis of Virus Lacking the NSs Gene, and Expression of a Foreign GeneJournal of Virology, 2006
- Rift Valley Fever Epidemic in Saudi Arabia: Epidemiological, Clinical, and Laboratory CharacteristicsClinical Infectious Diseases, 2003
- Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheepVaccine, 1991
- Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trialsVaccine, 1986
- Rift Valley fever virus vaccine trial: study of neutralizing antibody response in humansVaccine, 1985
- A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injectionVaccine, 1985